Ask Warren

CTC Bio

060590 · KOSDAQ · ₩060590 · 씨티씨바이오

₩2,585▼ ₩50 (1.90%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩34B₩34B₩32B₩23B₩35B₩34B₩41B₩36B
Cost of sales₩20B₩20B₩19B₩11B₩22B₩21B₩24B₩25B
Gross profit₩13B₩14B₩13B₩12B₩13B₩13B₩17B₩11B
Operating income₩3.8B₩4.6B₩1.5B₩1.6B₩2.3B₩916M₩812M−₩3B
Net income−₩898M₩3.5B₩2.9B−₩884M₩559M₩635M−₩2B−₩929M
Net income to shareholders₩2.6B₩3.5B₩1.1B₩310M₩1.2B₩635M₩502M−₩3.2B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩150B₩147B₩143B₩149B₩146B₩149B₩154B₩155B
Current assets₩78B₩75B₩69B₩75B₩70B₩70B₩74B₩74B
Cash and equivalents₩22B₩18B₩17B₩23B₩16B₩16B₩19B₩19B
Total liabilities₩71B₩70B₩71B₩77B₩74B₩79B₩84B₩85B
Current liabilities₩50B₩51B₩50B₩65B₩61B₩63B₩66B₩68B
Borrowings₩27B₩27B₩27B₩36B₩29B₩28B₩28B₩28B
Total equity₩79B₩76B₩73B₩72B₩71B₩70B₩70B₩70B
Shareholders' equity₩79B₩76B₩73B₩72B₩71B₩70B₩70B₩70B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩4.8B₩2.7B−₩4.5B₩5.6B₩7B−₩3.8B₩2.4B₩3.4B
Capital spending₩689M₩400M₩268M₩192M₩155M₩171M₩582M₩489M
Free cash flow₩4.1B₩2.3B−₩4.7B₩5.4B₩6.8B−₩4B₩1.8B₩2.9B

Consolidated where available. Amounts in won.

Also known as: CTC Bio / 씨티씨바이오 / 060590 / KRX:060590

Source: KRX statistical information